In this edition of Market Checkup, health-care analysts David Williamson and Max Macaluso discuss today's biggest health-care news, including Amgen's multibillion-dollar acquisition of oncology specialist Onyx Pharmaceuticals, Rigel Pharmaceuticals' latest clinical trial disappointment, new allegations of a big pharma's misconduct in China, and a new opportunity in Eli Lilly's animal health division.
Max Macaluso and Dave Williamson
Aug 26, 2013 at 7:01PM
Motley Fool Returns
Stock Advisor S&P 500
Stock Advisor launched in February of 2002. Returns as of 02/17/2020.Join Stock Advisor
Cumulative Growth of a $10,000 Investment in Stock Advisor Calculated by Time-Weighted Return
- "Sonic the Hedgehog" Rewards Paramount's Handling of Audience Complaints With a $57 Million Opening Weekend
- After 2020, Some Retirees Won't Be Able to Increase Their Social Security Benefits as Much
- Lots of Risks Remain at This 15.5%-Yielding Dividend Stock
- Is Panasonic Stock a Buy?
- 70% of Americans Are Dangerously Close to Major Financial Trouble